The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.

Uğraklı M., Koçak M. Z., Dinç G., Genç T. B., Çağlayan M., Uğraklı S., ...Daha Fazla

Journal of cancer research and clinical oncology, 2023 (SCI-Expanded)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1007/s00432-023-04844-6
  • Dergi Adı: Journal of cancer research and clinical oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: Renal cell carcinoma, Nivolumab, Proton pump inhibitor, Survival
  • Akdeniz Üniversitesi Adresli: Evet